Drug
Sof Vel
Sof Vel: highest development phase Phase 3, developed by Gilead Sciences. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| SOF/VEL NCT02201940 | Phase 3 | Hepatitis C Virus Infection |
| SOF/VEL NCT02300103 | Phase 2 | Hepatitis C Virus Infection |
Latest
No recent events.
Follow Sof Vel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.